Literature DB >> 33743679

The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.

Farid Gharibi1, Ali Imani2, Koustuv Dalal3.   

Abstract

BACKGROUND: The present study was designed and conducted to evaluate multiple sclerosis (MS) treatment costs and the resulting economic impact imposed on MS patients in Iran.
METHODS: This was a cross-sectional study, among randomly selected 300 MS patients, registered in the MS Association of East Azerbaijan Province, Iran (1 year after their treatment began). The regression analysis, ANOVA, T-test, and chi-square were used.
RESULTS: The average amount of out-of-pocket payments (OOPs) by MS patients during the previous year was 1669.20 USD, most of which was spent on medication, rehabilitation care, and physician visits. Their mean annual income was 5182.84 USD. Fifty four percent of families with an MS patient suffer from catastrophic health expenditure (CHE) and 44% experience poverty caused by the OOPs. Occupational status, having supplemental health insurance, and being residents of Tabriz significantly affect OOPs, CHE, and the resulting poverty (P < 0.05).
CONCLUSION: The catastrophic financial burden of health care costs on MS patients and their families justifies health policymakers to promote pre-payment systems and provide subsidies to less well-off patients to protect them from the unfairness of OOPs and its resulting CHE and poverty.

Entities:  

Keywords:  Catastrophic health expenditure; Multiple sclerosis; Out-of-pocket payment; Poverty caused by disease

Mesh:

Year:  2021        PMID: 33743679      PMCID: PMC7981983          DOI: 10.1186/s12913-021-06251-4

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  30 in total

1.  Catastrophic health payments and health insurance: some counterintuitive evidence from one low-income country.

Authors:  Björn Ekman
Journal:  Health Policy       Date:  2007-03-26       Impact factor: 2.980

2.  Health status of people with multiple sclerosis: a community mail survey.

Authors:  A Solari; D Radice
Journal:  Neurol Sci       Date:  2001-08       Impact factor: 3.307

Review 3.  Use and misuse of statistics for epidemiological studies of multiple sclerosis.

Authors:  P L Hibberd
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

4.  The role of disease and demographic factors in the employment of patients with multiple sclerosis.

Authors:  N LaRocca; R Kalb; P Kendall; L Scheinberg
Journal:  Arch Neurol       Date:  1982-04

5.  The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy.

Authors:  Maria Pia Amato; Mario A Battaglia; Domenico Caputo; Giovanni Fattore; Simone Gerzeli; Michele Pitaro; Arturo Reggio; Maria Trojano
Journal:  J Neurol       Date:  2002-02       Impact factor: 4.849

6.  A comprehensive assessment of the cost of multiple sclerosis in the United States.

Authors:  K Whetten-Goldstein; F A Sloan; L B Goldstein; E D Kulas
Journal:  Mult Scler       Date:  1998-10       Impact factor: 6.312

7.  Access to health care for people with multiple sclerosis.

Authors:  S L Minden; D Frankel; L Hadden; D C Hoaglin
Journal:  Mult Scler       Date:  2007-02-09       Impact factor: 6.312

8.  An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.

Authors:  V Casado; L Romero; L Gubieras; L Alonso; E Moral; S Martinez-Yelamos; A Martinez-Yelamos; O Carmona; T Arbizu
Journal:  Mult Scler       Date:  2007-03-15       Impact factor: 6.312

9.  Employment in individuals with multiple sclerosis.

Authors:  A B Kornblith; N G La Rocca; H M Baum
Journal:  Int J Rehabil Res       Date:  1986       Impact factor: 1.479

10.  Catastrophic health expenditures and its inequality in elderly households with chronic disease patients in China.

Authors:  Zhonghua Wang; Xiangjun Li; Mingsheng Chen
Journal:  Int J Equity Health       Date:  2015-01-20
View more
  1 in total

1.  Estimation the medical cost of multiple sclerosis in Iran; 2019-2020.

Authors:  Mina Asadollahi; Ali Darvishi; Amirreza Azimi; Majid Annabi; Zahra Jafariazar; Ramin Heshmat
Journal:  BMC Health Serv Res       Date:  2022-02-02       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.